• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

low stock

  1. Seriously, am I the only be who thinks...

    Am I the only one who thinks this place is going under? The future seems certain that the company will not make it. This is not a joke and how I pay for my family to eat. Why isn’t the board doing anything? Why is Pops still in charge? Do we have to hot below $5 a share for an alarm to go off...
    • anonymous
    • Thread
    • company closing low stock shutting down
    • Replies: 95
    • Forum: Alkermes
Top Bottom
Back